Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | العربية | Dansk | Nederlands | Filipino | Finnish | Ελληνικά | עִבְרִית | हिन्दी | Bahasa | Norsk | Русский | Svenska | Magyar | Polski | Română | Türkçe

Noonan Syndrome Causes

Recurrence in siblings and apparent transmission from parent to child has long suggested a genetic defect with autosomal dominant inheritance and variable expression. A person with NS has up to a 50% chance of transmitting it to a child. The fact that an affected parent is not always identified for children with NS suggests several possibilities:

  1. a parent could carry the gene without being affected (incomplete penetrance)
  2. manifestations are variably expressed and could be so subtle as to go unrecognized (variable expressivity)
  3. a high proportion of cases represent new, sporadic mutations or
  4. Noonan syndrome is heterogeneous, comprising more than one similar condition of differing cause, some not inherited.
TypeOMIMGeneDescription
NS1 PTPN11In most of the families with multiple affected members, NS maps to chromosome 12q24.1. In 2001, it was reported that approximately half of a group of patients with Noonan syndrome carried a mutation of the ''PTPN11'' gene at that location, which encodes protein tyrosine phosphatase SHP-2. The SHP2 protein is a component of several intracellular signal transduction pathways involved in embryonic development that modulate cell division, differentiation, and migration, including that mediated by the epidermal growth factor receptor. The latter pathway is important in the formation of the cardiac semilunar valves.
Chromosomal abnormalities, such as a duplication of chromosome region 12q24 encompassing gene ''PTPN11'' can result in an apparent Noonan syndrome.
NS2 unknown (autosomal recessive) 
NS3 KRASAdditional mutations in KRAS genes have been reported to cause Noonan syndrome in a smaller percentage of individuals with the syndrome.
NS4 SOS1It has recently been shown that activating mutations in SOS1 also give rise to NS. Shp2 and SOS1 both have roles as positive regulators of the Ras/MAP kinase pathway suggesting that dysregulation of this pathway may play a major role in the genesis of this syndrome.
NS5 RAF1Additional mutations in ''RAF1'' genes have been reported to cause Noonan syndrome in a smaller percentage of individuals with the syndrome.

A condition known as "neurofibromatosis-Noonan syndrome" is associated with neurofibromin.

Further Reading


This article is licensed under the Creative Commons Attribution-ShareAlike License. It uses material from the Wikipedia article on "Noonan syndrome" All material adapted used from Wikipedia is available under the terms of the Creative Commons Attribution-ShareAlike License. Wikipedia® itself is a registered trademark of the Wikimedia Foundation, Inc.